Professor Luke Vale Thomas Griffiths
| Systematic review and meta-analysis of photodynamic diagnosis of bladder cancer compared with white light cystoscopy | 2010 |
|
Professor Rakesh Heer Dr Trevor Dorkin Thomas Griffiths Laurence Rangecroft
| A prospective audit of hypospadias correction in a regional paediatric surgery centre | 2004 |
|
Thomas Griffiths Philip Powell David Thomas Professor David Neal John Kelly et al. | Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment | 2003 |
|
Thomas Griffiths Professor David Neal Philip Powell
| Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance | 2002 |
|
Dr Khaver Qureshi Thomas Griffiths Dr Mary Robinson Colin Marsh Dr James Roberts et al. | Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapy | 2001 |
|
Joanne Cresswell Dr Helen Robertson Professor David Neal Thomas Griffiths Emeritus Professor John Kirby et al. | Distribution of lymphocytes of the αEβ7 phenotype and E-cadherin in normal human urothelium and bladder carcinomas | 2001 |
|
Thomas Griffiths Kilian Mellon
| Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer | 2000 |
|
Professor Simi Ali Emmett O'Flaherty Thomas Griffiths Professor David Neal Emeritus Professor John Kirby et al. | Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4(+) T cell activation in vitro | 1999 |
|
Professor Simi Ali Thomas Griffiths Professor David Neal Emeritus Professor John Kirby
| Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+T cell activation in vitro | 1999 |
|
Thomas Griffiths Kilian Mellon
| Human papillomavirus and urological tumours: I. Basic science and role in penile cancer | 1999 |
|
Dr Khaver Qureshi Thomas Griffiths Dr Mary Robinson Dr James Roberts Professor John Lunec et al. | TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer | 1999 |
|
Dr Christine Challen Thomas Griffiths Dr Mary Robinson Professor David Neal Professor John Lunec et al. | Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: High frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis | 1998 |
|
Dr Khaver Qureshi Thomas Griffiths Dr Mary Robinson Reginald Hall Professor John Lunec et al. | Chemotherapy and muscle-invasive bladder cancer: Assessment of p53 immuno-reactivity (IR) as a predictor of response | 1998 |
|